Literature DB >> 12816614

Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIV.

Jinell B Mah Ming1, M John Gill.   

Abstract

A case report of drug-induced rhabdomyolysis in a 34-year-old HIV-infected male with a history of liver disease and concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir is presented.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12816614     DOI: 10.1089/108729103321655854

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  19 in total

1.  Life-threatening rhabdomyolysis following the interaction of two commonly prescribed medications.

Authors:  Alireza Fallah; Maitri Deep; David Smallwood; Peter Hughes
Journal:  Australas Med J       Date:  2013-03-31

Review 2.  Is There Potential for Repurposing Statins as Novel Antimicrobials?

Authors:  Emma Hennessy; Claire Adams; F Jerry Reen; Fergal O'Gara
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

3.  Safety and Efficacy of Atorvastatin in Human Immunodeficiency Virus-infected Children, Adolescents and Young Adults With Hyperlipidemia.

Authors:  Ann J Melvin; Grace Montepiedra; Lisa Aaron; William A Meyer; Hans M Spiegel; William Borkowsky; Mark J Abzug; Brookie M Best; Marilyn J Crain; Peggy R Borum; Bobbie Graham; Patricia Anthony; Katherine Shin; George K Siberry
Journal:  Pediatr Infect Dis J       Date:  2017-01       Impact factor: 2.129

4.  Alcoholic Extract of Lotus Leaves Improves Lipid Profile in Rats with HIV Protease Inhibitor-induced Dyslipidaemia.

Authors:  Q J Su; Z Z Lu; Q Y Deng; B M Wei
Journal:  West Indian Med J       Date:  2015-07-21       Impact factor: 0.171

5.  Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4.

Authors:  Daniel Q Li; Richard Kim; Eric McArthur; Jamie L Fleet; David G Bailey; David Juurlink; Salimah Z Shariff; Tara Gomes; Muhammad Mamdani; Sonja Gandhi; Stephanie Dixon; Amit X Garg
Journal:  CMAJ       Date:  2014-12-22       Impact factor: 8.262

Review 6.  Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitors.

Authors:  Benoit Chauvin; Sylvain Drouot; Aurélie Barrail-Tran; Anne-Marie Taburet
Journal:  Clin Pharmacokinet       Date:  2013-10       Impact factor: 6.447

7.  Risk management of simvastatin or atorvastatin interactions with CYP3A4 inhibitors.

Authors:  Espen Molden; Eva Skovlund; Pia Braathen
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

8.  Diagnose SARS-CoV-2 associated Guillain-Barre syndrome upon appropriate criteria and after exclusion of differentials.

Authors:  Josef Finsterer
Journal:  J Med Virol       Date:  2021-06-10       Impact factor: 20.693

9.  HIV and HAART-Associated Dyslipidemia.

Authors:  Eoin R Feeney; Patrick W G Mallon
Journal:  Open Cardiovasc Med J       Date:  2011-02-24

10.  The Relationship Between HIV Infection and Cardiovascular Disease.

Authors:  Birgitt Dau; Mark Holodniy
Journal:  Curr Cardiol Rev       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.